Nimbus, Bristol-Myers Drop Psoriasis Drug Dispute
Nimbus Therapeutics LLC agreed Tuesday to drop its case in New York federal court that sought to avoid selling Bristol-Myers Squibb Co. and its subsidiary Celgene Corp. a psoriasis drug the...To view the full article, register now.
Already a subscriber? Click here to view full article